Brazil | Regulatory Market Profile

Brazil medical device regulatory market profile

Update January 1, 2023

ANVISA & Related Regulatory Organizations

Learn more


Brazil Medical Device Regulations & Guidance

Brazil Medical Device Classifications

Medical Devices

ANVISA classifies medical devices, including IVDs, into the following classes:

Class I - Low risk. Examples include simple surgical instruments and tongue depressors.

Class III - High risk. Examples include dialyzers and orthopedic implants.

Class II - Medium risk. Examples include infusion pumps and powered wheelchairs.

Class IV - Highest risk. Examples include coronary stents.

ANVISA also has four types of device categories: medical equipment, materials for health use, orthopedic implants, and in vitro diagnostics.

Learn more

ANVISA medical devices

Medical Device Market Requirements in Brazil

Medical device manufacturers without a physical location in Brazil must appoint a Brazil Registration Holder (BRH) who will submit your registration application and maintain control of your device registration and Brazil Good Manufacturing Practice (B-GMP) certification. Note that registration transfers will require the cooperation of the previous BRH.

Note that while B-GMP is a separate standard, it is similar to ISO 13485 and the FDA's QSR and most devices which comply with either of these standards will comply with B-GMP.

Application forms must be completed in Portuguese, all other forms may be completed in Portuguese, Spanish, or English.

Learn more

ANVISA Instructions for registration

Learn more

Good Manufacturing Practices (GMP) - List of applicable regulations

Class I and Class II devices

Registrations for Class I and Class II devices do not expire and share similar requirements.

Brazil-GMP is required, but ANVISA will not audit compliance.

An abbreviated registration process (Cadestro) is followed, which requires a technical dossier that includes legal documents and labeling information.

Class III and Class IV devices

Class III and Class IV device registrations expire after 10 years.

A Brazil-GMP audit is required.

An ordinary registration process (Registro) is followed, which requires general device information, certificate of free sale, GMP, instruction manual and labeling, clinical data, and clinical study report (where applicable).

INMETRO certification

Some medical devices will require certification from The National Institute of Metrology, Standardization, and Industrial Quality (INMETRO) in order to obtain ANVISA certification. Devices that require INMETRO certification are primarily electro-medical devices subject to IEC 60601 and renewals are required every 5 years.

Learn more

INMETRO information

New regulations effective March 1, 2023

The new regulations that came into force on March 1, 2023 introduced some significant changes, including:

New classification rules for new technology, including Software as a Medical Device (SaMD) and nanomaterials.

Adoption of the IMDRF Table of Contents structure for technical dossiers.

Multiple rules advancing the consolidation and digitization of information.

Learn more

ANVISA updates rules for regularization of medical devices in Brazil

ANVISA Post-Market Requirements

ANVISA post-market responsibilities are shared by the manufacturer and the Brazil Registration Holder.  Requirements include post-market monitoring, reporting, and field safety corrective actions.  

Learn more

RDC No. 67/2009: Technovigilance rules

Learn more

RDC No. 551/2021: Notification of field actions by health product registration holders

Brazil UDI Requirements

UDI labeling requirements in Brazil come into effect as follows:

Class IV - June, 2024

Class III - January, 2025

Class II - January, 2026

Class I - January, 2028

Learn more

RDC No. 591/2021: Unique Identification of Medical Devices (UDI) system